COMMUNIQUÉS West-GlobeNewswire

Clairity Announces Update to NCCN Guidelines to Include AI Mammogram-Based Risk Tool to Identify Future Breast Cancer Risk in Women Missed by Traditional Methods
14/04/2026
Major paradigm shift incorporates five-year risk assessment and identifies increased-risk women beginning at age 35 BOSTON, April 14, 2026 (GLOBE NEWSWIRE) -- Clairity, Inc. announces the National Comprehensive Cancer [...]
Myriad Genetics Expands Access for MyChoice Test to Prostate Cancer Patients in Japan
14/04/2026
SALT LAKE CITY, April 14, 2026 (GLOBE NEWSWIRE) -- Myriad Genetics Inc. , (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that Japan’s Ministry of Health, Labour and [...]
Amneal Launches First Two Respiratory Metered-Dose Inhalation Products in the U.S.
14/04/2026
Launch of albuterol sulfate inhalation aerosol and beclomethasone dipropionate HFA inhalation aerosol BRIDGEWATER, N.J., April 14, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (“Amneal” or the “Company”) ( [...]
Corbus Pharmaceuticals Announces Last Patient First Visit in CANYON-1 Study of CRB-913 for the Treatment for Obesity
14/04/2026
On track to complete 16-week, dose-finding Phase 1b study (n=240) in summer 2026 Phase 1b data will build upon Phase 1a findings that demonstrated weight loss of nearly 3% at 14 days in individuals with obesity CRB-913 [...]
Clearmind Medicine’s CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder
14/04/2026
Vancouver, Canada, April 14, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non- [...]
GeneCentric to Present Data on Fragmentomics-Based ExpressCT™ Liquid Biopsy Technology at AACR 2026
14/04/2026
DURHAM, N.C., April 14, 2026 (GLOBE NEWSWIRE) -- GeneCentric , a company making precision medicine more precise by bringing gene expression biology to liquid biopsy, today announced that it will present three posters at [...]
Calidi Biotherapeutics Announces Speaker Presentation at IOVC Conference in Reykjavík, Iceland on April 28th Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
14/04/2026
SAN DIEGO, April 14, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will [...]
Nextech Reduces Healthcare’s Payment Reconciliation Burden with Reimagined Embedded Payment Processing Platform
14/04/2026
Nextech Payments, Powered by Stripe and Integrated with Affirm, Saves Medical Practices Hours Weekly Through Real-Time Automation TAMPA, Fla., April 14, 2026 (GLOBE NEWSWIRE) -- Nextech, an award-winning technology [...]
Nanox Announces Collaboration with Meir Medical Center to Deploy Nanox.ARC for Orthopedic Imaging Clinical Study
14/04/2026
Enhancing emergency triage imaging with Nanox.ARC to improve efficiency and lower radiation dose Collaboration expands clinical evidence base of Nanox.ARC to support broader adoption PETACH TIKVA, Israel, April 14, 2026 [...]
Rivus Pharmaceuticals Announces First Patients Dosed in AMPLIFY Phase 2 Trial for HU6 in MASH
14/04/2026
- Top-line data expected in mid-2027; Actively planning for HU6’s late-stage development in MASH - - HU6 is potential best-in-class oral MASH therapy designed to address unmet needs in MASH through a unique energy [...]
BioVie Announces Abstract Accepted for Presentation at the 2026 American Academy of Neurology Annual Meeting
14/04/2026
CARSON CITY, Nev., April 14, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ: BIVI) (“BioVie” or the “Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases [...]
Merakris Therapeutics and iFyber Collaboration Receives Top SAWC Research Award for MTX-001 Wound Healing Study in Human Skin Model
14/04/2026
Phase 2 Clinical Program Underway as Award-Winning Data Strengthen MTX-001’s Position in a Multi-Billion-Dollar Wound Care Market iFyber Partnership Integrates Advanced Tissue Models and Quantitative Bioanalytics to [...]
Hemp Hop Announces 420 Deals in Charlotte, NC with Buy 3, Get 1 Free 2026
14/04/2026
CHARLOTTE, N.C., April 14, 2026 (GLOBE NEWSWIRE) -- Hemp Hop , Charlotte's trusted cannabis brand, is officially launching its biggest 420 sale in Charlotte , NC to date. From April 17–20, 2026 , customers can take [...]
Hinge Bio Announces First Subject Dosed in Phase 1 Trial of HB2198, a Novel B cell Depleting Agent, for Treating Autoimmune Disease
14/04/2026
First-in-human clinical trial underway to evaluate safety, tolerability and pharmacodynamic activity of HB2198 in normal healthy volunteers. A separate Phase 1 trial evaluating HB2198 in patients with Systemic Lupus [...]
Biomerica Launches inFoods® IBS in Canada Through Partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs
14/04/2026
— Represents Biomerica’s First Commercial Entry into the Canadian Market for its Precision, Diagnostic-Guided Therapy — Canada Has One of the Highest IBS Prevalence Rates in the World — an Estimated 18% vs. 11% Globally [...]
Aclarion Receives Pinnacle Award for AI Innovation
14/04/2026
Recognition Follows 2025 HLTH Digital Health Award for Nociscan Award Winning AI Targets a Large and Costly Chronic Low Back Pain Market BROOMFIELD, Colo., April 14, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc ., (“Aclarion [...]
Join Nexalin’s Exclusive Live Investor Webinar and Q&A Session on April 21
14/04/2026
ORLANDO, FL, April 14, 2026 (GLOBE NEWSWIRE) -- RedChip Companies will host an investor webinar on April 21, 2026, at 4:15 p.m. ET with Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW). The exclusive event will feature [...]
Community Routes: Access to Mental Health Care Provides Continued Funding for Mental Health Services at Free & Charitable Clinics
14/04/2026
Supplemental funding helps 11 free & charitable clinics and charitable pharmacies expand mental health care and reach more patients in underserved communities SANTA BARBARA, Calif. and PARSIPPANY, N.J., April 14, [...]
Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts
14/04/2026
Adds dedicated business development leadership to support Tempest’s strategic priorities Will lead China outreach and cross-border partnership efforts To support ongoing partnering discussions for Phase 3-ready [...]

Pages